The relevance of a deep analysis of tumor mutational profile in a study of METamp as a consequence of EGFR TKIs resistance therapies detected clones displaying METamp at a shallow frequency before any treatment with an EGFR TKI, suggesting that these clones were selected under therapeutic pressure [92]. This evidence concerns the gene EGFR and neoplasm.